Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of August 27, 2026, KRRO trades at $13.81 with a market cap of $202.18M and a P/E ratio of -1.38. KRRO moved +0.98% today. Year to date, KRRO is +69.94%; over the trailing twelve months it is -32.48%. Its 52-week range spans $5.20 to $55.89. Analyst consensus is strong buy with an average price target of $18.71. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks KRRO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $13.81 |
| Market Cap | $202.18M |
| P/E Ratio | -1.38 |
| EPS | $-10.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.89 |
| 52-Week Low | $5.20 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.38M |
| Net Income | $-106.64M |
| Gross Margin | 0.00% |
8 analysts cover KRRO: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.71.